NCT01120132View on ClinicalTrials.gov

Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis

PHASE2CompletedINTERVENTIONAL
Enrollment

716

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Allergic Conjunctivitis
Interventions
DRUG

CsA high dose

Solution of Cyclosporine (high dose) administered during 28 days

DRUG

CsA low dose

Solution of Cyclosporine (low dose) administered during 28 days

DRUG

PA

Suspension of Prednisolone Acetate administered during 28 days

DRUG

Placebo

Placebo solution administered during 28 days

Trial Locations (1)

01810

ORA, Andover

Sponsors
All Listed Sponsors
lead

Fovea Pharmaceuticals SA

INDUSTRY